John Pippen
Medical Oncology · Dallas, TXNPI 1649213521
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $3,200 of the $3,508 with a category attached, or 91.2%. Pfizer accounts for 83.3% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2019 at $3,086 and has fallen 99.0% since, to $31 in 2021. That places this record below the midpoint for medical oncology clinicians in TX, where the typical reported total is $4,372.
Across 16 payments — averaging $219.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$3K
- Athenex Pharmaceutical Division, LLC$350
- Puma Biotechnology, Inc.$64
- AstraZeneca$38
- Takeda Pharmaceuticals U.S.A., Inc.$23
- Astellas Pharma US Inc$19
- plus $90 from 7 others
Across 1 payment — averaging $299,347 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novartis$299K
What the payments were for
- Speaking & faculty fees$3,20091%
- Food & beverage$2968%
- Education$120%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 2 | $2,923 |
| Athenex Pharmaceutical Division, LLC | 2 | $350 |
| Puma Biotechnology, Inc. | 1 | $64 |
| AstraZeneca | 2 | $38 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
| Astellas Pharma US Inc | 1 | $19 |
| Sanofi | 1 | $16 |
| Pharmacyclics LLC, An Abbvie Company | 1 | $15 |
| Blueprint Medicines Corporation | 1 | $13 |
| Amgen | 1 | $12 |
| Novartis | 1 | $12 |
| Gilead | 1 | $12 |
| Merck | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TALZENNA$2,850
How this compares
$3,508 in reported general payments places this provider in the 45th percentile of 495 medical oncology providers in Texas.
Other medical oncology in Dallas
- Moshe LevyDallas$5.1M
- Andrew WhiteleyDallas$1.7M
- Eric NadlerDallas$1.6M
- Joyce O'ShaughnessyDallas$1.3M
- Ronan KellyDallas$1.1M
- Thomas HutsonDallas$944K
- Heather McArthurDallas$314K
- Tian ZhangDallas$286K
- Micah BurchDallas$221K
- David JohnsonDallas$212K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.